1. Home
  2. PRAX vs AEHR Comparison

PRAX vs AEHR Comparison

Compare PRAX & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • AEHR
  • Stock Information
  • Founded
  • PRAX 2015
  • AEHR 1977
  • Country
  • PRAX United States
  • AEHR United States
  • Employees
  • PRAX N/A
  • AEHR N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • AEHR Electrical Products
  • Sector
  • PRAX Health Care
  • AEHR Industrials
  • Exchange
  • PRAX Nasdaq
  • AEHR Nasdaq
  • Market Cap
  • PRAX 952.1M
  • AEHR 974.9M
  • IPO Year
  • PRAX 2020
  • AEHR 1997
  • Fundamental
  • Price
  • PRAX $52.00
  • AEHR $25.85
  • Analyst Decision
  • PRAX Strong Buy
  • AEHR
  • Analyst Count
  • PRAX 10
  • AEHR 0
  • Target Price
  • PRAX $93.30
  • AEHR N/A
  • AVG Volume (30 Days)
  • PRAX 435.3K
  • AEHR 2.0M
  • Earning Date
  • PRAX 11-05-2025
  • AEHR 10-06-2025
  • Dividend Yield
  • PRAX N/A
  • AEHR N/A
  • EPS Growth
  • PRAX N/A
  • AEHR N/A
  • EPS
  • PRAX N/A
  • AEHR N/A
  • Revenue
  • PRAX $7,765,000.00
  • AEHR $56,818,000.00
  • Revenue This Year
  • PRAX N/A
  • AEHR $6.19
  • Revenue Next Year
  • PRAX $20.00
  • AEHR $33.87
  • P/E Ratio
  • PRAX N/A
  • AEHR N/A
  • Revenue Growth
  • PRAX 338.45
  • AEHR N/A
  • 52 Week Low
  • PRAX $26.70
  • AEHR $6.27
  • 52 Week High
  • PRAX $91.83
  • AEHR $34.35
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 56.68
  • AEHR 44.38
  • Support Level
  • PRAX $46.99
  • AEHR $29.41
  • Resistance Level
  • PRAX $55.86
  • AEHR $34.35
  • Average True Range (ATR)
  • PRAX 3.62
  • AEHR 2.38
  • MACD
  • PRAX 0.56
  • AEHR -0.65
  • Stochastic Oscillator
  • PRAX 74.41
  • AEHR 29.43

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

Share on Social Networks: